LENZ Therapeutics, Inc.
Biotechnology company · Solana Beach, California, United States · Nasdaq: LENZ
LENZ Therapeutics, Inc. is a biotechnology company headquartered in Solana Beach, California, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker LENZ. It has reported private securities offerings to the US SEC, most recently $83 million sold in a notice filed in 2023.
LENZ Therapeutics at a glance
What does LENZ Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $83.5 million sold (2023).
Frequently asked questions about LENZ Therapeutics
Where is LENZ Therapeutics headquartered?
LENZ Therapeutics, Inc. is headquartered in Solana Beach, California, United States.
What does LENZ Therapeutics do?
LENZ Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is LENZ Therapeutics a public company?
Yes. LENZ Therapeutics, Inc. trades on Nasdaq under the ticker LENZ.
When was LENZ Therapeutics founded?
The earliest incorporation on record for LENZ Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- MacConnell Research CorporationSolana Beach, California, United States
- Spinnaker Biosciences, Inc.Solana Beach, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences